Series C funding round for VYNE Therapeutics raising $51M in July 2017
Series C funding round for VYNE Therapeutics raising $51M in July 2017
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$51M
Top Valuation
-
VYNE Therapeutics raised $51M in a Series C round.
The round was announced on 07/01/17.